New MOAs in prostate cancer treatment - what’s next?

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Social determinants and survival outcomes in early-onset colorectal cancer in the US

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabetics

ASCO 2025: Update on blood-based cancer assays

Ecological evaluation of climate risks for cancer survivors

Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

Exercise programme may lower risk of recurrence and death for some colon cancer survivors

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma